Search results
Oct 26, 2021 · Jerry McMahon, Ph.D., Resigns from Harpoon as President and Chief Executive Officer. Scott Myers, Current Member of Harpoon’s Board of Directors Named Chair, Replacing Ron...
- Harpoon Therapeutics
Oct 26, 2021 · Eastland will succeed Jerry McMahon, Ph.D., who has resigned from his position as President and Chief Executive Officer and as a member of the company’s Board of Directors (the “Board”). Dr....
As announced by Harpoon Therapeutics Inc. in a news release and in a regulatory filing published on Tuesday, October 26, 2021, Gerald (Jerry) McMahon leaves his post as chief executive officer at the clinical-stage immunotherapy company, after about five years in the role, effective immediately.
Sep 7, 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.
Jerry McMahon has over 30 years of biotechnology leadership, scientific innovation, deal-making, and financing experience. With broad disease-area expertise and a specialty in oncology therapeutics, he has held scientific, pharmaceutical, and venture capital positions, as well as CEO or president positions in multiple biotechnology companies, ...
View Jerry McMahon’s profile on LinkedIn, a professional community of 1 billion members. Dr. McMahon brings more than 30 years of exceptional biotechnology leadership, scientific…
- STORM Therapeutics
Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.
